The number of tumor-infiltrating CD8-positive T cells was significantly higher in the invasive front than in the tumor center in both MCPyV-positive (p = 0.001) and -negative (p < 0.0001) MCC cases (Fig. 3a). The gene discussed is CD8A; the disease is Merkel cell skin cancer.